Back
The Arena Group Holdings Vs. Summit Therapeutics Industry Stock Comparison
Sell
23
AREN
The Arena Group Holdings
Last Price:
0.85
Seasonality Move:
37.14%
Buy
85
SMMT
Summit Therapeutics
Last Price:
26.20
Seasonality Move:
26.72%
Sell
23
The Arena Group Holdings (AREN)
is a Sell
Is The Arena Group Holdings a Buy, Sell or Hold?
- The current The Arena Group Holdings [AREN] share price is $0.88. The Score for AREN is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- AREN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
85
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $29.48. The Score for SMMT is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
AREN Stock Price Chart
What is The Arena Group Holdings's stock price today?
-
The The Arena Group Holdings share price today is $0.88
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AREN is experiencing slight buying pressure.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $29.48
The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
AREN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 48.53 | Sell |
Chaikin Money Flow: | 5127 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.83 - 0.95) | Sell |
Bollinger Bands (100): | (0.79 - 0.91) | Buy |
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.35 | Buy |
Relative Strength Index (14 RSI): | 80.76 | Buy |
Chaikin Money Flow: | -10383890 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.54 - 21.66) | Buy |
Bollinger Bands (100): | (4.24 - 14.54) | Buy |
AREN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.9 | Sell |
20-day SMA: | 0.91 | Sell |
50-day SMA: | 0.89 | Sell |
200-day SMA: | 1.22 | Sell |
8-day EMA: | 0.9 | Sell |
20-day EMA: | 0.9 | Sell |
50-day EMA: | 0.89 | Sell |
200-day EMA: | 1.57 | Sell |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.3 | Buy |
20-day SMA: | 16.66 | Buy |
50-day SMA: | 12.66 | Buy |
200-day SMA: | 6.49 | Buy |
8-day EMA: | 23.98 | Buy |
20-day EMA: | 18.55 | Buy |
50-day EMA: | 13.95 | Buy |
200-day EMA: | 7.85 | Buy |
The Arena Group Holdings Earnings Growth & AREN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.59 per share, and a decrease next year of $0.00 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
The Arena Group Holdings Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Therapeutics Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |